tagrissoresults.com - Efficacy of TAGRISSO® (osimertinib) in Resectable EGFRm NSCLC

home > domains > tagrissoresults.com

Description: Read about the ADAURA study design & efficacy of TAGRISSO® (osimertinib) as an adjuvant treatment for patients with resectable EGFRm NSCLC.

Example domain paragraphs

SELECT AN INDICATION

In resectable EGFRm NSCLC

UPDATED DFS DATA WITH ADDITIONAL 2 YEARS OF FOLLOW-UP